BeStock  
Stocks › Medical Devices › NVCR

Novocure NVCR

US equityMarket cap rank #3014Medical Devices
$10.71 +$0.02 (+0.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.71 0.00%
Open$10.61
Prev close$10.69
Day range$10.61 – $11.06
Volume1.64M
Market cap$1.25B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$193.40M+15.7% YoY
Operating profit-$6.17M+82.9% YoY
Net profit-$10.44M+72.0% YoY
Diluted EPS-$0.09+72.7% YoY
Free cash flow$15.75M+5.5% YoY
Operating cash flow$22.67M

Revenue, last 8 quarters

$161.3MDec '24$155.0MMar '25$158.8MJun '25$167.2MSep '25$174.4MDec '25$174.1MMar '26$183.6MJun '26$193.4MSep '26

Net profit, last 8 quarters

$-65.9MDec '24$-34.3MMar '25$-40.1MJun '25$-37.3MSep '25$-24.5MDec '25$-71.1MMar '26$-15.7MJun '26$-10.4MSep '26

Diluted EPS by quarter

-0.61Dec '24-0.31Mar '25-0.36Jun '25-0.33Sep '25-0.22Dec '25-0.62Mar '26-0.13Jun '26-0.09Sep '26

Free cash flow by quarter

$-12.4MDec '24$-46.3MMar '25$-21.4MJun '25$14.9MSep '25$-22.9MDec '25$-18.7MMar '26$1.2MJun '26$15.7MSep '26

Annual revenue

$494.4MFY20$535.0MFY21$537.8MFY22$509.3MFY23$605.2MFY24$655.4MFY25

Profitability & balance sheet

Gross margin77.0%
Operating margin-17.2%
Net margin-16.8%
Return on equity-35.2%
Return on assets-11.1%
Return on invested capital-14.1%
Current ratio2.49
Liabilities / assets57.7%
Cash & investments$463.48M
Total debt$231.55M
Net cash (debt)$231.93M

Where the revenue comes from

Quarter 2025/FY

By region

  • United States$385.63M 58.8%
  • Germany$79.41M 12.1%
  • France$76.19M 11.6%
  • Other international markets$56.90M 8.7%
  • Japan$37.79M 5.8%
  • Greater China$19.44M 3.0%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $193.40M $183.58M $174.06M $655.35M $174.35M
Total Operating Revenue $193.40M $183.58M $174.06M $655.35M $174.35M
Cost of Revenue $44.53M $41.11M $38.93M $166.88M $42.16M
Gross Profit $148.87M $142.48M $135.13M $488.47M $132.19M
Operating Expense $155.04M $153.04M $202.55M $642.27M $172.59M
Selling and Admin Expenses $96.94M $101.59M $144.21M $417.73M $111.68M
-Selling & Marketing Expense $53.30M $61.68M $58.36M $240.06M $68.66M
-General & Admin Expense $43.65M $39.91M $85.85M $177.67M $43.02M
Research & Development $58.10M $51.45M $58.34M $224.54M $60.91M
Operating Profit -$6.17M -$10.56M -$67.42M -$153.80M -$40.39M
Net Non-Operating Interest Income (Expense) -$1.71M -$1.89M -$1.84M $21.87M $3.76M
Total Other Finance Costs $1.71M $1.89M $1.84M -$26.04M -$7.92M
Pretax Profit -$7.88M -$12.45M -$69.26M -$136.25M -$40.95M
Tax $2.56M $3.21M $1.88M -$23,000.00 -$16.46M
Net Profit -$10.44M -$15.66M -$71.14M -$136.23M -$24.50M
Profit from Continuing Operations -$10.44M -$15.66M -$71.14M -$136.23M -$24.50M
Net Income to Parent Company -$10.44M -$15.66M -$71.14M -$136.23M -$24.50M
Net Income to Common Stockholders -$10.44M -$15.66M -$71.14M -$136.23M -$24.50M
Basic EPS -$0.09 -$0.13 -$0.62 -$1.22 -$0.22
Diluted EPS -$0.09 -$0.13 -$0.62 -$1.22 -$0.22
Non-Operating Interest Income – – – $12.87M –
Non-Operating Interest Expense – – – $17.04M –
Other Income (Expense) – – – -$4.32M –
Gain on Sale of Security – – – -$4.32M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $828.71M $795.19M $787.93M $804.33M $804.33M
Total Current Assets $673.52M $638.52M $631.66M $646.73M $646.73M
Cash and Cash Equivalents & Short-Term Investments $463.48M $440.56M $432.00M $447.67M $447.67M
-Cash and Cash Equivalents $96.73M $93.70M $87.53M $93.55M $93.55M
-Short Term Investments $366.75M $346.86M $344.48M $354.13M $354.13M
Receivables $159.33M $145.82M $146.40M $138.45M $138.45M
-Accounts Receivable $108.26M $91.46M $93.27M $89.44M $89.44M
-Other Receivables $51.07M $54.36M $53.13M $49.01M $49.01M
Inventory $40.61M $42.22M $43.46M $41.11M $41.11M
Restricted Cash $10.11M $9.92M $9.80M $9.84M $9.84M
Total Non-Current Assets $155.19M $156.67M $156.26M $157.60M $157.60M
Net PPE $144.09M $145.74M $145.06M $147.00M $147.00M
-Gross PPE $144.09M $145.74M $145.06M $216.26M $216.26M
Other Non-Current Assets $11.10M $10.93M $11.20M $10.60M $10.60M
Total Liabilities $478.10M $457.10M $457.21M $463.86M $463.86M
Total Current Liabilities $270.66M $220.71M $217.58M $223.23M $223.23M
Payables $245.66M $220.71M $217.58M $122.56M $122.56M
-Accounts Payable $145.92M $130.73M $127.24M $122.23M $122.23M
-Other Payable $99.74M $89.98M $90.34M $327,000.00 $327,000.00
Short-Term Debt and Capital Lease Obligation $25.00M – – $11.66M $11.66M
-Current Debt $25.00M – – – –
Total Non-Current Liabilities $207.44M $236.39M $239.63M $240.63M $240.63M
Long Term Debt and Capital Lease Obligation $206.55M $233.42M $234.94M $236.69M $236.69M
-Long Term Debt $171.34M $195.89M $195.46M $195.05M $195.05M
-Long Term Capital Lease Obligation $35.22M $37.53M $39.48M $41.65M $41.65M
Employee Benefits $882,000.00 $2.97M $4.69M $3.94M $3.94M
Total Equity $350.61M $338.09M $330.72M $340.47M $340.47M
Stockholders' Equity $350.61M $338.09M $330.72M $340.47M $340.47M
Capital Stock $0.00 $0.00 $0.00 $0.00 $0.00
-Common Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.74B $1.72B $1.70B $1.63B $1.63B
Retained Earnings -$1.39B -$1.38B -$1.36B -$1.29B -$1.29B
Gains/Losses Not Affecting Retained Earnings -$1.59M -$3.42M -$4.90M -$3.44M -$3.44M
Prepaid Assets – – – $9.66M $9.66M
-Accumulated Depreciation – – – -$69.26M -$69.26M
Current Accrued Expenses – – – $73.06M $73.06M
-Current Capital Lease Obligation – – – $11.66M $11.66M
Current Deferred Liabilities – – – $15.95M $15.95M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $22.67M $8.13M -$13.52M -$49.03M -$18.00M
Net cash flow from continuing operations $22.67M $8.13M -$13.52M -$49.03M -$18.00M
Net Income from Continuing Operations -$10.44M -$15.66M -$71.14M -$136.23M -$24.50M
Gain/Loss from Continuing Operations -$1.02M $17,000.00 $477,000.00 $1.25M -$961,000.00
Depreciation & Depletion & Amortization $4.42M $4.31M $4.12M $14.65M $4.22M
Other Non-Cash Items -$516,000.00 $104,000.00 -$219,000.00 $4.95M $513,000.00
Change in Working Capital $12.51M $4.21M -$7.87M -$20.08M -$15.28M
-Change in Receivables -$13.41M $424,000.00 $828,000.00 -$38.94M -$23.46M
-Change in Inventory $1.95M $866,000.00 -$2.78M -$5.67M -$1.98M
-Change in Payables and Accrued Expense $25.16M $2.80M -$5.12M $18.96M $8.44M
-Change in Other Current Assets $2.31M $2.91M $2.04M $10.85M $4.37M
-Change in Other Current Liabilities -$3.50M -$2.79M -$2.84M -$5.27M -$2.64M
Net cash flow from investing -$23.24M -$6.38M $7.75M $437.28M $336.33M
Net Cash Flow from Continuing Investing Activities -$23.24M -$6.38M $7.75M $437.28M $336.33M
Net PPE Purchase and Sale -$6.92M -$6.92M -$5.15M -$26.65M -$4.90M
Net Investment Purchase and Sale -$16.32M $538,000.00 $12.90M $463.92M $341.22M
Financing Cash Flow $3.64M $4.55M -$166,000.00 -$451.34M -$559.49M
Net Cash Flow from Continuing Financing Activities $3.64M $4.55M -$166,000.00 -$451.34M -$559.49M
Net Issuance Payments Of Debt $0.00 $0.00 $0.00 -$460.97M -$560.95M
Net Common Stock Issuance $0.00 $2.09M $0.00 $3.66M $1.52M
Proceeds from Stock Option Exercised $3.64M $2.46M $390,000.00 $6.11M $77,000.00
Ending Cash Balance $106.84M $103.62M $97.32M $103.39M $103.39M
Net Change in Cash $3.07M $6.30M -$5.94M -$63.10M -$241.17M
Beginning Cash Balance $103.62M $97.32M $103.39M $166.09M $344.64M
Effect of Exchange Rate Changes $149,000.00 -$8,000.00 -$130,000.00 $394,000.00 -$76,000.00
Free Cash Flow $15.75M $1.22M -$18.67M -$75.68M -$22.90M
Net Other Financing Charges – – -$556,000.00 -$146,000.00 –

Discussion

No comments yet — be the first to weigh in on NVCR.

Sign in to join the discussion.

Scroll to Top